HNRNPA2B1 and non-small cell lung carcinoma: Remarkably, only the SUMOylation inhibitor 2-D08 significantly reduced expression of the >40 kDa band (Fig. 4a), suggesting that circTLCD4-RWDD3-bound hnRNPA2B1 is partially SUMOylated in NSCLC.